(Q38106667)

English

A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative.

scientific article published on 13 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

disease prevention

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Roger S. Blumenthal

8

object named as

Roger S Blumenthal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Michael J Blaha

9

object named as

Michael J Blaha

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Steven Hsu

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Van-Khue Ton

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Dominique Ashen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Seth S Martin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Ty J Gluckman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Payal Kohli

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Stephen D Sisson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

13 May 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Clinical Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

383-393

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

A Convenient Tool to Profile Patients for Generalized Cardiovascular Disease Risk in Primary Care

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Predicting the 30-year risk of cardiovascular disease: the framingham heart study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Further improvements in CHD risk prediction for women

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Multi-Ethnic Study of Atherosclerosis: objectives and design

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH Registry.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Current strategies for ischemic stroke prevention: role of multimodal combination therapies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Medical therapy in peripheral artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Effects of intensive blood-pressure control in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Thiazide diuretics in advanced chronic kidney disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Atherogenic dyslipidemia: cardiovascular risk and dietary intervention

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Lipoprotein(a) and ischemic heart disease--a causal association? A review

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Risks associated with statin therapy: a systematic overview of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

The controversies of statin therapy: weighing the evidence

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Combination therapy of statins and fibrates in the management of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Nicotinic acid as a lipid-modifying drug--a review

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Nicotine receptor partial agonists for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Nicotine replacement therapy for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Standards of medical care in diabetes--2010.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Effects of physical activity on cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Using pedometers to increase physical activity and improve health: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

A Prospective Study of Walking as Compared with Vigorous Exercise in the Prevention of Coronary Heart Disease in Women

1 reference

https://api.crossref.org/works/10.1002%2FCLC.22137

21 January 2018

Physical activity and mortality in older men with diagnosed coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The "Million Hearts" initiative--preventing heart attacks and strokes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quitting smoking among adults--United States, 2001-2010.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statins and safety: can we finally be reassured?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparing the new European cardiovascular disease prevention guideline with prior American Heart Association guidelines: an editorial review

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association of changes in physical-activity level and other lifestyle characteristics with mortality among men

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23670948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CLC.22137

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23670948%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38106667&oldid=2114640822"